ArticleInternational journal of cancer2019

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma.

Lindi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.